Endocrine · Nov 16, 2026
Remnant cholesterol and incident type 2 diabetes: a systematic review and meta-analysis of cohort studies
By Xu M, Jin X, Tang W et al.
Background Remnant cholesterol (RC), the cholesterol content of triglyceride-rich lipoproteins and their remnants, has emerged as a potential cardiometabolic risk marker. This systematic review and meta-analysis evaluated the association between RC and incident type 2 diabetes mellitus (T2DM). Methods PubMed, Embase, Cochrane Library, Scopus, and Web of Science were searched from inception to November 14, 2025, for cohort studies examining RC and incident T2DM. Risk of bias was assessed using the Risk Of Bias In Non-randomized Studies of Exposures (ROBINS-E) tool. Pooled risk estimates with 95% CIs were calculated using fixed- or random-effects models. Sensitivity, subgroup, and publication bias analyses were performed. Results Ten studies comprising 11 cohort datasets and 9,001,947 participants were included, with 602,043 incident T2DM cases. Compared with the lowest baseline RC category, the highest category was associated with increased incident T2DM risk (pooled RR = 1.78, 95% CI: 1.50–2.11). Each 1 mmol/L increase in baseline RC was associated with higher risk (pooled HR = 1.43, 95% CI: 1.26–1.63), as was each 1-standard deviation increase (pooled HR = 1.13, 95% CI: 1.07–1.20). Higher cumulative RC levels were also associated with increased T2DM risk. Sensitivity and subgroup analyses generally supported the robustness of the findings. Conclusions Higher RC levels were consistently associated with an increased risk of incident T2DM across categorical, continuous, and cumulative exposure analyses. Given that RC can be estimated from routine lipid profiles, it may serve as an accessible complementary marker for T2DM risk stratification. However, the substantial heterogeneity and observational nature of the evidence warrant cautious interpretation. Clinical trial number Not applicable.